Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
KLRS
Stock Latest News
Market News
CRWV, CVBF, KLRS — Insiders Are Buying These 3 Stocks
9d ago
CRWV
CVBF
Premium
Pre-Earnings
Kalaris Therapeutics, Inc. (KLRS) Q1 Earnings Cheat Sheet
16d ago
KLRS
Premium
The Fly
Starbucks upgraded, Doximity downgraded: Wall Street’s top analyst calls
20d ago
TM
AIZ
Premium
The Fly
Wedbush bullish on Kalaris Therapeutics, initiates with an Outperform
20d ago
KLRS
Premium
The Fly
Kalaris Therapeutics initiated with an Outperform at Wedbush
20d ago
KLRS
Premium
The Fly
Kalaris Therapeutics price target lowered to $25 from $26 at Citizens
21d ago
KLRS
Premium
The Fly
Kalaris Therapeutics reports Q1 EPS (46c), consensus (52c)
22d ago
KLRS
Premium
The Fly
Kalaris Therapeutics initiated with an Overweight at Morgan Stanley
2M ago
KLRS
Premium
Company Announcements
Kalaris Therapeutics Announces CFO Resignation, Finance Leadership Shift
2M ago
8K
KLRS
Premium
Ratings
Kalaris Therapeutics: Early TH103 Data in nAMD Support Buy Rating and Favorable Risk/Reward Despite Manufacturing Hurdles
3M ago
KLRS
Premium
The Fly
Kalaris Therapeutics reports FY25 EPS ($2.85), consensus ($3.70)
3M ago
KLRS
Premium
The Fly
Kalaris Therapeutics sees cash runway into 4Q27
3M ago
KLRS
Premium
Company Announcements
Kalaris Updates TH103 Strategy and Highlights Cash Runway
3M ago
8K
KLRS
Premium
Weekend Updates
Vizsla, Coty, Kalaris, Annexon, Brown & Brown Trending
5M ago
BRO
ANNX
Premium
The Fly
Kalaris Therapeutics initiated with a Buy at Chardan
5M ago
KLRS
Premium
Ratings
Early Clinical Strength and Durability of TH103 Underpin Buy Rating on Kalaris Therapeutics
5M ago
KLRS
Premium
Company Announcements
Kalaris Therapeutics Announces Oversubscribed $50 Million Financing
6M ago
8K
KLRS
Premium
The Fly
Kalaris Therapeutics price target raised to $26 from $20 at Citizens
6M ago
KLRS
Premium
The Fly
Kalaris Therapeutics announces $50M private placement
6M ago
KLRS
Premium
The Fly
Kalaris Therapeutics expects cash, equivalents to fund operations into 3Q27
6M ago
KLRS
Premium
Company Announcements
Kalaris Therapeutics Announces Positive Phase 1a Trial Data
6M ago
8K
KLRS
Premium
The Fly
Kalaris Therapeutics announces initial data from TH103 trial
6M ago
KLRS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
